Publications by authors named "Ueki Nobue"

Background: Since it is difficult for expert endoscopists to diagnose early gastric cancer in post-eradication status, it may be critical to evaluate the stratification of high-risk groups using the advance of gastric atrophy or intestinal metaplasia. We tried to determine whether the combination of endoscopic artificial intelligence (AI) diagnosis for the evaluation of gastric atrophy could be a useful tool in both pre- and post-eradication status.

Methods: 270 -positive outpatients (Study I) were enrolled and Study II was planned to compare patients ( = 72) with pre-eradication therapy with post-eradication therapy.

View Article and Find Full Text PDF

Background: Although a new potassium-competitive acid blocker (P-CAB) vonoprazan has been developed in Japan, no data are available regarding long-term vonoprazan or vonoprazan and acotiamide combination treatment in patients with functional dyspepsia (FD).

Methodology: A total of 73 consecutive patients with FD diagnosed according to the Rome III classification were enrolled. Forty-two patients with FD were treated with vonoprazan monotherapy and thirty-one patients with FD were treated with vonoprazan and acotiamide combination therapy for 24 weeks.

View Article and Find Full Text PDF
Article Synopsis
  • - This study investigated the link between specific genetic variations (SNPs) related to chronic pancreatitis and clinical features of patients with intraductal papillary mucinous neoplasm (IPMN).
  • - A total of 100 patients with IPMN and 116 control patients were analyzed, measuring various serum enzyme levels and performing endosonography to evaluate the severity of the condition.
  • - Findings indicated that certain genotypes, particularly for carboxypeptidase A1 and gamma-glutamyltransferase 1, may help diagnose and predict concerning features of IPMN, such as cyst size.
View Article and Find Full Text PDF

Objectives: Pancreatic fibrosis is one of the main pathological features of chronic pancreatitis (CP), suggesting a strong relationship between CP and pancreatic ductal cancer. There was no available data about pancreatic fibrosis and pancreatic dysfunction in the early CP (ECP) using endosonography (EUS).

Methods: Asymptomatic patients with pancreatic enzyme abnormalities (AP-P; = 56) and patients with ECP ( = 21) were determined by the absence of abnormal findings on upper gastrointestinal endoscopy, abdominal ultrasonography, and abdominal computed tomography.

View Article and Find Full Text PDF

Background And Aim: Apolipoprotein A2 (apoA2) isoforms have been reported to undergo the aberrant processing in pancreatic cancer and pancreatic risk populations compared with that in healthy subjects. This study aimed to clarify whether apoA2 isoforms were as useful as N-benzoyl-p-aminobenzoic acid (BT-PABA) test for exocrine pancreatic dysfunction markers in patients with early chronic pancreatitis (ECP).

Methods: Fifty consecutive patients with functional dyspepsia with pancreatic enzyme abnormalities (FD-P) (n = 18), with ECP (n = 20), and asymptomatic patients with pancreatic enzyme abnormalities (AP-P) (n = 12) based on the Rome IV classification and the Japan Pancreatic Association were enrolled in this study.

View Article and Find Full Text PDF
Article Synopsis
  • - The study aimed to investigate differences in clinical characteristics and pancreatic enzyme abnormalities between patients with functional dyspepsia (FD) alone and those with FD overlapping with irritable bowel syndrome (IBS).
  • - Results showed that patients with FD-IBS overlap reported worse symptoms after eating high-fat meals, even though pancreatic enzyme abnormalities were more prevalent in FD alone patients.
  • - The presence of elevated levels of protease-activated receptor 2 (PAR2) in degranulated eosinophils in the duodenum was found to be significantly higher in the FD-IBS overlap group, suggesting a link to the condition's pathophysiology.
View Article and Find Full Text PDF

Background: This study aimed to clarify whether any risk factors including clinical characteristics, endosonographic features, and exocrine pancreatic dysfunction may be useful for a predictive factor for patients with early chronic pancreatitis.

Methods: A total of 163 consecutive patients that presented with functional dyspepsia with pancreatic enzyme abnormalities (FD-P) (n = 46), early chronic pancreatitis (ECP) (n = 47), and asymptomatic patients with pancreatic enzyme abnormalities (AP-P) (n = 70) based on the Rome III classification and the Japan Pancreatic Association were included in this study. The enrolled patients were evaluated using endosonography (EUS) and EUS elastography.

View Article and Find Full Text PDF

Background: Early chronic pancreatitis (ECP) has been reported to advance into chronic pancreatitis, it may be critical to differentiate the pathophysiology of ECP and functional dyspepsia (FD) in patients with pancreatic enzyme abnormalities (FD-P). This study aimed to clarify differences in the pathophysiology of ECP and FD-P and to determine whether duodenal inflammatory responses in the two diseases were associated with protease-activated receptor (PAR) 2, as the trypsin receptor.

Methods: Eighty patients who presented with FD-P and ECP were enrolled.

View Article and Find Full Text PDF

Background And Aim: Gastric atrophy is a precancerous lesion. We aimed to clarify whether gastric atrophy determined by artificial intelligence (AI) correlates with the diagnosis made by expert endoscopists using several endoscopic classifications, the Operative Link on Gastritis Assessment (OLGA) classification based on histological findings, and genotypes associated with gastric atrophy and cancer.

Methods: Two hundred seventy -positive outpatients were enrolled.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to compare clinical symptoms and eating patterns between patients with functional dyspepsia (FD) and those with functional dyspepsia along with pancreatic enzyme abnormalities (FD-P) in Singapore and Japan.
  • A total of 198 patients were analyzed, focusing on various clinical characteristics, symptoms related to dietary fat intake, and related questionnaires assessing anxiety and quality of life.
  • The findings revealed that while there were no major demographic or clinical differences between the two groups, FD-P patients experienced significantly more epigastric pain and early satiety after fat meals, suggesting these symptoms could help differentiate between the two conditions, particularly in Japan.
View Article and Find Full Text PDF

We have reported that refractory functional dyspepsia patients with pancreatic enzyme abnormalities (FD-P). We tried to analyze the prevalence of exocrine pancreatic insufficiency (EPI) in FD-P patients to clarify whether the pathophysiology of FD patients including clinical symptoms and quality of life were associated with EPI. We enrolled forty-nine patients presenting with typical symptoms of FD-P patients ( = 20) and asymptomatic patients with pancreatic enzyme abnormalities (AP-P) ( = 29).

View Article and Find Full Text PDF

Since there were no available data about colonic diverticular bleeding in extremely elderly patients (>80 years old) treated with direct oral anticoagulants (DOACs), we tried to determine clinical characteristics in those with colonic diverticular bleeding taking DOACs and to compare clinical outcomes of those in DOAC-treated to those in warfarin-treated . We enrolled DOAC-treated ( = 20) and warfarin-treated ( = 23) extremely elderly patients with diverticular bleeding diagnosed by colonoscopy. We performed a retrospective review of patients' medical charts and endoscopic findings.

View Article and Find Full Text PDF

Since the prevention of early chronic pancreatitis (ECP) into chronic pancreatitis might be critical for the reduction of pancreatic cancer, we tried to clarify the pathophysiology of ECP patients, focusing on ECP patients without alcoholic chronic pancreatitis. 27 ECP patients without alcoholic chronic pancreatitis and 33 patients with functional dyspepsia with pancreatic enzyme abnormalities (FD-P) were enrolled in this study. Diagnosis of ECP was made when imaging findings showed the presence of more than 2 out of 7 endoscopic ultrasound features.

View Article and Find Full Text PDF

Background: To determine whether central and in vitro administration of urocortin 2 (Ucn 2) affected intestinal inflammatory responses in LPS-stimulated rat models and macrophage cell lines and acotiamide modified mucosal inflammation in this model.

Methods: Rats were divided into four groups. LPS-stimulated group (n = 4); LPS- and urocortin 2-treated group (n = 4); LPS- and acotiamide-treated group (n = 4); and LPS-, urocortin 2-, and acotiamide-treated group (n = 4).

View Article and Find Full Text PDF

Background And Aims: Three-dimensional (3D) rigid endoscopy has been clinically introduced in surgical fields to enable safer and more accurate procedures. To explore the feasibility of 3D flexible endoscopy, we conducted a study comparing 2-dimensional (2D) and 3D visions for the performance of esophageal endoscopic submucosal dissection (ESD).

Methods: Six endoscopists (3 experts and 3 trainees) performed ESD of target lesions in isolated porcine esophagus using a prototype 3D flexible endoscope under 2D or 3D vision.

View Article and Find Full Text PDF
Article Synopsis
  • - Functional dyspepsia (FD) significantly reduces quality of life, requiring bothersome symptoms for diagnosis, while early chronic pancreatitis (ECP) was introduced to allow timely treatment before progression.
  • - There is limited data on the relationship between ECP and FD, particularly concerning symptoms like severe epigastric pain, early satiety, and abdominal fullness.
  • - Endosonography can differentiate between ECP and FD patients, especially those with pancreatic enzyme issues, indicating a need for further research on why some FD patients with these abnormalities develop ECP.
View Article and Find Full Text PDF

Background And Aims: To determine whether serum acylated ghrelin levels were associated with anxiety, clinical symptoms, depressive status, quality of life, gastric motility and endoscopic findings based on Kyoto classification in functional dyspepsia (FD) patients.

Methods: We enrolled three groups, FD patients ( = 15) with high levels of acylated ghrelin, FD patients ( = 33) with normal levels of acylated ghrelin and FD patients ( = 35) with low levels of acylated ghrelin. There was no significant differences in the positivity of infection among the three groups.

View Article and Find Full Text PDF

Background: There was no available data concerning the clinical differentiation between the updated definition of early chronic pancreatitis (ECP) and anti-acid therapy-resistant functional dyspepsia (RFD).

Aims: We aimed to determine whether clinical symptoms, gastric motility, psychogenic factors and fat intake can help distinguish early chronic pancreatitis (ECP) from anti-acid therapy-resistant functional dyspepsia patients with pancreatic enzyme abnormalities (RFD-P) and anti-acid therapy-resistant functional dyspepsia (RFD) patients using endosonography.

Methods: We enrolled 102 consecutive patients presenting with typical symptoms of RFD patients (n = 52), ECP patients (n = 25) and RFD-P patients (n = 25).

View Article and Find Full Text PDF
Article Synopsis
  • The study aims to investigate the pathophysiological differences between early chronic pancreatitis (ECP), functional dyspepsia with pancreatic enzyme abnormalities (FD-P), and functional dyspepsia (FD), and to assess the effectiveness of a triple therapy involving camostat mesilate, pancrelipase, and rabeprazole in improving FD symptoms among these patients.
  • A total of 84 patients were enrolled, including those with FD, ECP, and FD-P, and gastric emptying was measured using a specific breath test.
  • The results showed that ECP and FD-P patients had greater female representation and more significant gastric emptying disturbances than FD patients; the triple therapy notably reduced epigastric pain in E
View Article and Find Full Text PDF

There was not available data about the overlap between functional dyspepsia (FD) and pancreatic diseases. We aimed to determine whether epigastric pain syndrome (EPS) accompanying with pancreatic enzyme abnormalities were associated with early chronic pancreatitis proposed by Japan Pancreas Society (JPS) using endosonography. We enrolled 99 consecutive patients presenting with typical symptoms of FD, including patients with postprandial distress syndrome (PDS) ( = 59), EPS with pancreatic enzyme abnormalities ( = 41) and EPS without pancreatic enzyme abnormalities ( = 42) based on Rome III criteria.

View Article and Find Full Text PDF

Background/aims: We aimed to clarify whether cyclooxygenase-2 (COX-2) and microsomal prostaglandin E synthase-1 (mPGES-1) genotypes were associated with certain histological findings and endoscopical appearances based on Kyoto classification.

Methods: We enrolled 285 Helicobacter pylori-infected gastritis patients. Genotypes of COX-2 1195, COX-2 1290, mPGES-1, interleukin-1β (IL-1β) 511 and tumour necrosis factor-α (TNF-α) 308 were analyzed.

View Article and Find Full Text PDF

Background: Recent updated guidelines of the Japanese Society of Gastroenterology recommend the use of a single dose of antiplatelet agents in patients undergoing endoscopic submucosal dissection (ESD). However, the postoperative bleeding risk after gastric ESD associated with the continuation or interruption of antithrombotic therapy remains controversial. We aimed to evaluate whether certain factors including interrupted antithrombotic therapy could affect early and delayed post-ESD bleeding risk.

View Article and Find Full Text PDF

An 81-year-old man was admitted with upper abdominal pain and weight loss. Esophagogastroduodenoscopy revealed a large tumor located from the gastric angle to the body. Histological analysis of a biopsy revealed a moderately differentiated adenocarcinoma.

View Article and Find Full Text PDF

Background: Impact of acid suppressants on lower gastrointestinal bleeding remains unclear in low-dose aspirin users; we aimed to investigate this relationship.

Methods: Retrospective cohort study of low-dose aspirin users who underwent coronary angiography for ischaemic heart disease in our institution between October 2005 and December 2006; patients were evaluated for upper or lower gastrointestinal bleedings within 3 years post-angiography.

Results: 538 patients were enrolled (males, 74.

View Article and Find Full Text PDF